XML 39 R19.htm IDEA: XBRL DOCUMENT
v3.22.4

ACCRUED EXPENSES AND OTHER LIABILITIES | 12 Months Ended
--- | ---
Dec. 31, 2022
Accrued Liabilities and Other Liabilities [Abstract] |
ACCRUED EXPENSES AND OTHER LIABILITIES | ACCRUED EXPENSES AND OTHER LIABILITIES
|  | December 31, 2022 |  | December 31, 2021
(In millions) |  | Accrued Expenses |  | Non-Current Liabilities |  | Total |  | Accrued Expenses |  | Non-Current Liabilities |  | Total
Salaries and wages |  | $ | 259 |  |  | $ | — |  |  | $ | 259 |  |  | $ | 210 |  |  | $ | — |  |  | $ | 210 |
Deferred compensation |  | 5 |  |  | 80 |  |  | 85 |  |  | 6 |  |  | 91 |  |  | 97 |
Pension and other employee benefits |  | 29 |  |  | 179 |  |  | 208 |  |  | 29 |  |  | 188 |  |  | 217 |
Insurance obligations (1) |  | 179 |  |  | 309 |  |  | 488 |  |  | 186 |  |  | 311 |  |  | 497 |
Operating taxes (2) |  | 132 |  |  | — |  |  | 132 |  |  | 166 |  |  | — |  |  | 166 |
Interest |  | 41 |  |  | — |  |  | 41 |  |  | 37 |  |  | — |  |  | 37 |
Deposits, mainly from customers |  | 84 |  |  | — |  |  | 84 |  |  | 95 |  |  | — |  |  | 95 |
Operating lease liabilities (3) |  | 191 |  |  | 541 |  |  | 732 |  |  | 100 |  |  | 256 |  |  | 356 |
Deferred revenue (4) |  | 178 |  |  | 366 |  |  | 544 |  |  | 183 |  |  | 411 |  |  | 594 |
Other (5) |  | 102 |  |  | 93 |  |  | 195 |  |  | 108 |  |  | 57 |  |  | 165 |
Total |  | $ | 1,200 |  |  | $ | 1,568 |  |  | $ | 2,768 |  |  | $ | 1,120 |  |  | $ | 1,314 |  |  | $ | 2,434 |
_______________ (1) Insurance obligations are primarily comprised of self-insured claim liabilities. (2) 2021 amount includes the deferral of certain payroll taxes allowed under the CARES Act. (3) Refer to Note 24, "Acquisitions", for further information. (4) Refer to Note 4, "Revenue", for further information. (5) As of December 31, 2022, and 2021, includes $13 million and $8 million, respectively, of restructuring liabilities related to the exit of the FMS U.K. business. Refer to Note 21, "Other Items Impacting Comparability" for further information. We recognized a benefit of $25 million in 2022 and $6 million in 2021 within earnings from continuing operations from the favorable development of estimated prior years claims where costs were lower than self-insured loss reserves. We recognized a charge of $18 million in 2020 within earnings from continuing operations from the unfavorable development of estimated prior years claims where costs exceeded self-insured loss reserves.

X
- Definition Description and amounts of accrued and non-current liabilities disclosure at the end of the reporting period. Amounts exclude deferred income taxes. + References No definition available. + Details
Name: | r_AccruedExpensesAndOtherLiabilitiesTextBlock
Namespace Prefix: | r_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration